Omid Holdings (Omid Holdings) Debt-to-Revenue : 0.00 (As of . 20)

View and export this data going back to . Start your Free Trial

What is Omid Holdings Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Omid Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was $0.00 Mil. Omid Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was $0.00 Mil. Omid Holdings's annualized Revenue for the quarter that ended in . 20 was $0.00 Mil.

Omid Holdings Debt-to-Revenue Historical Data

The historical data trend for Omid Holdings's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omid Holdings Debt-to-Revenue Chart

Omid Holdings Annual Data

Trend

Debt-to-Revenue

Omid Holdings Quarterly Data

Debt-to-Revenue

Competitive Comparison of Omid Holdings's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Omid Holdings's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Omid Holdings's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Omid Holdings's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Omid Holdings's Debt-to-Revenue falls into.

Omid Holdings Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Omid Holdings's Debt-to-Revenue for the fiscal year that ended in . 20 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(	+	)	/	N/A
	=	N/A

Omid Holdings's annualized Debt-to-Revenue for the quarter that ended in . 20 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(	+	)	/	0
	=	N/A

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (. 20) Revenue data.

Omid Holdings Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Omid Holdings's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Omid Holdings (Omid Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Omid Holdings Inc (OTCPK:OMID) » Definitions » Debt-to-Revenue

Traded in Other Exchanges

N/A

Address

1130 Springtown Road, Suite B, Phillipsburg, NJ, USA, 08865

Website

https://www.omidholdingsinc.com

Omid Holdings Inc is a health and wellness company. It is specialized in the sale and manufacture of CBD-based products. The company manufactures and sells branded inhalable, sublingual, and topical hemp-derived consumer goods. Its brands include Naturally Peaked Health, Shangri-La Life, and Peac Wellness. The company also offers design, development, manufacturing services to clients in the CBD-based cannabis industry.